Literature DB >> 25609766

Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.

Jiwon Oh1, Elias S Sotirchos2, Shiv Saidha2, Anna Whetstone2, Min Chen2, Scott D Newsome2, Kathy Zackowski2, Laura J Balcer2, Elliot Frohman2, Jerry Prince2, Marie Diener-West2, Daniel S Reich2, Peter A Calabresi1.   

Abstract

OBJECTIVE: To assess relationships between spinal cord MRI (SC-MRI) and retinal measures, and to evaluate whether these measures independently relate to clinical disability in multiple sclerosis (MS).
METHODS: One hundred two patients with MS and 11 healthy controls underwent 3-tesla brain and cervical SC-MRI, which included standard T1- and T2-based sequences and diffusion-tensor and magnetization-transfer imaging, and optical coherence tomography with automated segmentation. Clinical assessments included visual acuity (VA), Expanded Disability Status Scale, MS functional composite, vibration sensation threshold, and hip-flexion strength. Regions of interest circumscribing SC cross-sections at C3-4 were used to obtain cross-sectional area (CSA), fractional anisotropy (FA), perpendicular diffusivity (λ⊥), and magnetization transfer ratio. Multivariable regression assessed group differences and SC, retinal, and clinical relationships.
RESULTS: In MS, there were correlations between SC-CSA, SC-FA, SC-λ⊥, and peripapillary retinal nerve fiber layer (pRNFL) (p = 0.01, p = 0.002, p = 0.001, respectively) after adjusting for age, sex, prior optic neuritis, and brain atrophy. In multivariable clinical models, when SC-CSA, pRNFL, and brain atrophy were included simultaneously, SC-CSA and pRNFL retained independent relationships with low-contrast VA (p = 0.04, p = 0.002, respectively), high-contrast VA (p = 0.06, p = 0.008), and vibration sensation threshold (p = 0.01, p = 0.05). SC-CSA alone retained independent relationships with Expanded Disability Status Scale (p = 0.001), hip-flexion strength (p = 0.001), and MS functional composite (p = 0.004).
CONCLUSIONS: In this cross-sectional study of patients with MS, correlations exist between SC-MRI and retinal layers, and both exhibit independent relationships with clinical dysfunction. These findings suggest that the SC and optic nerve reflect ongoing global pathologic processes that supplement measures of whole-brain atrophy, highlighting the importance of combining measures from unique compartments to facilitate a thorough examination of regional and global disease processes that contribute to clinical disability in MS.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 25609766      PMCID: PMC4336102          DOI: 10.1212/WNL.0000000000001257

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Adjusting for multiple testing--when and how?

Authors:  R Bender; S Lange
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

3.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.

Authors:  N Evangelou; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

4.  The adaptive bases algorithm for intensity-based nonrigid image registration.

Authors:  Gustavo K Rohde; Akram Aldroubi; Benoit M Dawant
Journal:  IEEE Trans Med Imaging       Date:  2003-11       Impact factor: 10.048

5.  Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis.

Authors:  D Toussaint; O Périer; A Verstappen; S Bervoets
Journal:  J Clin Neuroophthalmol       Date:  1983-09

6.  Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype.

Authors:  G J Nijeholt; E Bergers; W Kamphorst; J Bot; K Nicolay; J A Castelijns; J H van Waesberghe; R Ravid; C H Polman; F Barkhof
Journal:  Brain       Date:  2001-01       Impact factor: 13.501

7.  Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.

Authors:  Jiwon Oh; Kathleen Zackowski; Min Chen; Scott Newsome; Shiv Saidha; Seth A Smith; Marie Diener-West; Jerry Prince; Craig K Jones; Peter C M Van Zijl; Peter A Calabresi; Daniel S Reich
Journal:  Mult Scler       Date:  2012-08-13       Impact factor: 6.312

8.  Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients.

Authors:  E Fisher; R A Rudick; G Cutter; M Baier; D Miller; B Weinstock-Guttman; M K Mass; D S Dougherty; N A Simonian
Journal:  Mult Scler       Date:  2000-12       Impact factor: 6.312

Review 9.  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

Authors:  H Lassmann; W Brück; C Lucchinetti
Journal:  Trends Mol Med       Date:  2001-03       Impact factor: 11.951

10.  The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results.

Authors:  Joseph C J Bot; Erwin L A Blezer; Wouter Kamphorst; Geert J Lycklama A Nijeholt; Herman J Ader; Jonas A Castelijns; Klaas Nicolay Ig; Elisabeth Bergers; Rivka Ravid; Chris Polman; Frederik Barkhof
Journal:  Radiology       Date:  2004-09-22       Impact factor: 11.105

View more
  25 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Authors:  Angeliki Filippatou; Thomas Shoemaker; Megan Esch; Madiha Qutab; Natalia Gonzalez-Caldito; Jerry L Prince; Ellen M Mowry; Peter A Calabresi; Shiv Saidha; Elias S Sotirchos
Journal:  Mult Scler       Date:  2018-12-03       Impact factor: 6.312

3.  Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.

Authors:  Biao Xiang; Jie Wen; Anne H Cross; Dmitriy A Yablonskiy
Journal:  J Magn Reson Imaging       Date:  2018-08-29       Impact factor: 4.813

Review 4.  Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.

Authors:  Allan R Martin; Izabela Aleksanderek; Julien Cohen-Adad; Zenovia Tarmohamed; Lindsay Tetreault; Nathaniel Smith; David W Cadotte; Adrian Crawley; Howard Ginsberg; David J Mikulis; Michael G Fehlings
Journal:  Neuroimage Clin       Date:  2015-12-04       Impact factor: 4.881

5.  Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.

Authors:  Benjamin Knier; Gildas Leppenetier; Carmen Wetzlmair; Lilian Aly; Muna-Miriam Hoshi; Verena Pernpeintner; Viola Biberacher; Achim Berthele; Mark Mühlau; Claus Zimmer; Bernhard Hemmer; Thomas Korn
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

Review 6.  Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?

Authors:  Jeffrey Lambe; Olwen C Murphy; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2018-03-21       Impact factor: 3.598

Review 7.  Monitoring the Course of MS With Optical Coherence Tomography.

Authors:  Alexander U Brandt; Elena H Martinez-Lapiscina; Rachel Nolan; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

Review 8.  Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Authors:  Jiwon Oh; Daniel Ontaneda; Christina Azevedo; Eric C Klawiter; Martina Absinta; Douglas L Arnold; Rohit Bakshi; Peter A Calabresi; Ciprian Crainiceanu; Blake Dewey; Leorah Freeman; Susan Gauthier; Roland Henry; Mathilde Inglese; Shannon Kolind; David K B Li; Caterina Mainero; Ravi S Menon; Govind Nair; Sridar Narayanan; Flavia Nelson; Daniel Pelletier; Alexander Rauscher; William Rooney; Pascal Sati; Daniel Schwartz; Russell T Shinohara; Ian Tagge; Anthony Traboulsee; Yi Wang; Youngjin Yoo; Tarek Yousry; Yunyan Zhang; Nancy L Sicotte; Daniel S Reich
Journal:  Neurology       Date:  2019-02-20       Impact factor: 9.910

Review 9.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

10.  Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.

Authors:  Nabil K El Ayoubi; Stephanie Ghassan; Marianne Said; Joelle Allam; Hala Darwish; Samia J Khoury
Journal:  J Neurol       Date:  2016-08-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.